Sep 2026· Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas· Vol 25, pp. 869-880· 0 citations
TL;DR
Overall, curcumin suppresses breast cancer progression by upregulating miR-181b and downregulating Bcl-2 and downregulating Bcl-2 in a dose-dependent manner.
Abstract
Curcumin, a natural compound from Curcuma longa, exerts anti-tumor activity in breast cancer, but the exact mechanism remains unclear. This study, after exposing to curcumin (0, 10, 30, and 60 μM), MTT, CCK-8 assays, and Flow cytometry analyzed human breast cancer cell viability, proliferation, and apoptosis. miR-181b and Bcl-2 levels were measured through qRT-PCR, and Western blot analysis of Bcl-2 protein level. Dual-luciferase assay and RIP confirmed interaction between miR-181b and Bcl-2. The results indicated that curcumin inhibited cell proliferation and promoted apoptosis in a dose-dependent manner. Curcumin treatment upregulated miR-181b expression, leading to the downregulation of Bcl-2. The miR-181b inhibitor reversed 30 μM curcumin-mediated proliferation and apoptosis, while elevated miR-181b reduced Bcl-2 levels. Furthermore, silencing both miR-181b and Bcl-2 impaired cell proliferation and enhanced apoptosis compared to silencing only miR-181b in 30 μM curcumin-treated breast cancer. Overall, curcumin suppresses breast cancer progression by upregulating miR-181b and downregulating Bcl-2.
Triple-negative breast cancer (TNBC) is widely
considered as one of the most challenging and
aggressive forms of breast cancer with poor prognosis
and limited treatment options. TNBC progression is
associated with aberrant dysregulation of microRNAs
(miRNAs) and oncogenic pathways like PI3K/AKT,
which promote cell prol...
Sharanya K., A. K. A. Mandal· Research journal of biotechn...· 0 citations
This study aims to investigate whether G-Re exerts anti-tumor effects in CRC by modulating miR-4516. The anti-proliferative effect of G-Re was evaluated by CCK-8 (IC₅₀ calculation). MiR-4516 expression was detected via qRT-PCR. Functional assays (proliferation, migration, invasion) were performed after transfection wit...
Ze-Ming Bai, Zhuo-Ran Li, Li-Fen Mu et al.· Acta Poloniae Pharmaceutica...· 0 citations
Findings identify SC as a potential structural scaffold exhibiting preliminary anti-tumor activity against breast cancer cells, at least in part, through modulating miR-21 and inhibition of the AKT/mTOR/ERK1/2 survival network.
Y. R. Shahin, N. Elguindy, D. Ghareeb et al.· Pharmaceuticals· 0 citations
Findings provide the first evidence that PD16 exerts pro-apoptotic effects in CRC cells through the AKT/GSK3β pathway inhibition, thereby confirming it as a valuable novel therapeutic candidate for CRC.
M. Yao, Wei Zhang, Dong Xu et al.· European Journal of Pharmaco...· 0 citations